ロード中...
Efficacy of the Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 in Mice—Further Evaluation
BACKGROUND: Human parainfluenza virus type 1 (hPIV-1) causes serious respiratory tract infections, especially in children. This study investigated the efficacy of the novel hemagglutinin-neuraminidase (HN) inhibitor BCX 2798 in the prophylaxis of lethal and the treatment of non-lethal parainfluenza...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2782883/ https://ncbi.nlm.nih.gov/pubmed/19918093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP1420 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|